Lipid phosphatases as dynamic regulators of protein conformation
脂质磷酸酶作为蛋白质构象的动态调节剂
基本信息
- 批准号:10005416
- 负责人:
- 金额:$ 24.89万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-09-23 至 2022-08-31
- 项目状态:已结题
- 来源:
- 关键词:Active SitesAlanineAllelesAmino AcidsAmyotrophic Lateral SclerosisBindingBinding SitesBiological AssayC-terminalCatalytic DomainCellsCharcot-Marie-Tooth DiseaseComplexCryoelectron MicroscopyDiseaseDistalDominant-Negative MutationEngineeringEnzymesFailureFluorescence Resonance Energy TransferFutureGenetic ScreeningImpairmentInternationalJournalsLaboratoriesLinkLipidsMalignant NeoplasmsMammalsMapsMentorsMichiganModelingMolecular ConformationMusMutagenesisMutateMutationNeurodegenerative DisordersOrangesPTEN genePTEN proteinPaperPathologyPathway interactionsPeripheral Nervous System DiseasesPhasePhenotypePhosphatidylinositolsPhosphoric Monoester HydrolasesPhosphorylationPhosphorylation SitePhosphotransferasesPoint MutationProtein ConformationProtein DephosphorylationProtein phosphataseProteinsProteomicsRecombinant ProteinsRegulationResearchRoentgen RaysRoleRotationScaffolding ProteinScanningSignal PathwaySiteStimulusStructureSurfaceSystemTailTestingTrainingVariantWritingYeastsbasecrosslinkdisease-causing mutationenzyme modelhuman diseaseimprovedin vivomeetingsmouse developmentmutantnovelphosphatidylinositol 3,4,5-triphosphatephosphatidylinositol 3,5-diphosphatepreventprotein protein interactionstudent participationtissue culturetumorundergraduate studentunnatural amino acidsyeast genetics
项目摘要
Abstract: Mutations in phosphatidylinositol (PI) phosphatases cause diseases including cancer and
neurodegenerative disorders. A common assumption is that failure to dephosphorylate a specific lipid substrate
underlies these diseases. Emerging evidence raises the possibility that PI phosphatases have lipid-
phosphatase-independent functions that contribute to disease pathology when these enzymes are mutated. In
support of this hypothesis, mutations that inactivate some PI phosphatases result in phenotypes that are
different from a total loss of the protein. This proposal will test the hypothesis that conformational changes that
accompany the regulation of the activity of PI phosphatases influence their interactions with protein partners.
The disease related PI phosphatases PTEN and Fig4 will be used as model enzymes. The mentored phase of
this proposal will take place in the laboratory of Dr. Lois Weisman, a leading expert in the phosphatidylinositol
3,5-bisphosphate (PI3,5P2) signaling pathway. In pursuit of the proposed research, the applicant will be trained
in large scale genetic screens in yeast, genetic incorporation of unnatural amino acids for probing dynamic
protein-protein interactions (with Dr. Ann Mapp, U. Michigan), and mammalian tissue culture. In addition to
research, the mentored phase will include: writing scientific papers, presentations at national and/or
international meetings, mentoring of undergraduate and graduate rotation students, and participation in local
journal and research clubs. In the independent phase, the applicant will establish an academic laboratory
where the applicant proposes to use both yeast and mammalian systems to elucidate principles of cross-talk
between cellular pathways via lipid-phosphatase-independent functions of PI phosphatases. Aim 1 will
characterize unpublished Fig4 mutants that either activate or inhibit Fab1 kinase activity and screen for new
mutants. In Aim 2 these mutants will be used to determine how Fig4 regulates PI3,5P2 via regulation of the
Fab1/Vac14/Fig4 complex. Fig4 domains involved in protein-protein interactions will be probed through
incorporation of photo-activatable amino acid cross-linkers in Fig4 using nonsense suppression. The potential
for Fig4 to act as a protein phosphatase will be tested by identifying phosphorylation sites altered in cells
expressing wild-type versus catalytically inactive Fig4. These and future studies will test the hypothesis that
specific stimuli, which induce conformational changes in yeast Fig4, in turn activate or inhibit Fab1. Aim 3 will
determine the roles of the PTEN active site in a regulatory intramolecular interaction with the C-terminal tail.
Binding assays between PTEN active site mutants and variants of the C-terminal tail will be performed both in
intact cells and with recombinant proteins. In addition, proteins that specifically interact with active or inactive
PTEN conformations will be identified via purification of native complexes associated with TAP-tagged mutants
from intact cells. These studies will test the hypothesis that conformational changes regulating PTEN lipid
phosphatase activity serve in parallel to regulate downstream pathways through protein-protein interactions.
摘要:磷脂酰肌醇(PI)磷酸酶的突变引起癌症和疾病
神经退行性疾病。一个常见的假设是,未能去磷酸化特定的脂质底物
这些疾病是基础。新兴证据提高了PI磷酸酶的脂质 -
当这些酶突变时,磷酸酶独立的功能会导致疾病病理。在
支持这一假设,使某些PI磷酸酶失活的突变导致表型
与蛋白质的总损失不同。该提议将检验以下假设,即构象变化
伴随着PI磷酸酶活性的调节会影响其与蛋白质伴侣的相互作用。
与疾病相关的PI磷酸酶PTEN和FIF4将用作模型酶。指导的阶段
该建议将在磷脂酰肌醇的领先专家Lois Weisman博士的实验室中进行。
3,5-双磷酸(PI3,5P2)信号通路。为了追求拟议的研究,申请人将接受培训
在酵母中的大规模遗传筛选中,非天然氨基酸的遗传掺入用于探测动态
蛋白质 - 蛋白质相互作用(与密歇根州的Ann Mapp博士)和哺乳动物组织培养。此外
研究,指导阶段将包括:撰写科学论文,国家和/或
国际会议,指导本科生和研究生轮换学生以及参加当地
期刊和研究俱乐部。在独立阶段,申请人将建立一个学术实验室
申请人建议同时使用酵母菌和哺乳动物系统来阐明交叉原理
PI磷酸酶的脂质磷酸酶独立于脂质磷酸酶的功能之间的细胞途径之间。目标1意志
表征未发表的FIG4突变体,该突变体激活或抑制Fab1激酶活性和新的筛选
突变体。在AIM 2中,这些突变体将用于确定FIF4如何通过调节来调节PI3,5P2
Fab1/vac14/fig4复合物。涉及蛋白质 - 蛋白质相互作用的FIG4结构域将通过
使用胡说八道的抑制在FIG4中掺入光活化氨基酸交联。潜力
为了使图4充当蛋白质磷酸酶,将通过鉴定细胞中改变的磷酸化位点进行测试
表达野生型与催化无活性的无效图4。这些和未来的研究将检验以下假设
诱导酵母FIG4构象变化的特定刺激反过来激活或抑制Fab1。目标3意志
确定PTEN活性位点与C末端尾部分子内相互作用中的作用。
PTEN活性位点突变体之间的结合测定和C末端的变体将在
完整的细胞和重组蛋白。另外,专门与活动或非活性相互作用的蛋白质
将通过纯化与Tapged突变体相关的天然复合物来识别PTEN构象
来自完整的细胞。这些研究将检验以下假设:构象变化调节PTEN脂质
磷酸酶的活性并联,可以通过蛋白质蛋白质相互作用来调节下游途径。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Multiple pathways for Fig4 contributions to cellular homeostasis in yeast.
Fig4 对酵母细胞稳态的贡献有多种途径。
- DOI:
- 发表时间:2022
- 期刊:
- 影响因子:0
- 作者:Khan,Imran;Reeves,HannahE;Darbro,CarolineS;Hall,HarrisonS;Strunk,BethanyS
- 通讯作者:Strunk,BethanyS
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Bethany S Strunk其他文献
Bethany S Strunk的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Bethany S Strunk', 18)}}的其他基金
Lipid phosphatases as dynamic regulators of protein conformation
脂质磷酸酶作为蛋白质构象的动态调节剂
- 批准号:
9355654 - 财政年份:2016
- 资助金额:
$ 24.89万 - 项目类别:
Lipid phosphatases as dynamic regulators of protein conformation
脂质磷酸酶作为蛋白质构象的动态调节剂
- 批准号:
9164702 - 财政年份:2016
- 资助金额:
$ 24.89万 - 项目类别:
相似国自然基金
肠道微生态介导的苯丙氨酸代谢在三七皂苷抑制缺血性脑卒中继发性血栓形成中的作用机制研究
- 批准号:82304488
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
自由短肽微阵列用于高通量筛选二苯丙氨酸基抗菌肽
- 批准号:52303206
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于iPSC来源的类器官模型研究PHOX2B丙氨酸重复序列突变在肠脑神经系统中的致病效应及分子机制
- 批准号:
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:
L-苯丙氨酸通过lncRNA CHRF/miR-182-5p/BNIP3介导的线粒体自噬在人工甜味剂导致NAFLD中的机制研究
- 批准号:82370862
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
γ-干扰素介导SRSF3色氨酸-苯丙氨酸替代翻译在胃癌免疫微环境中的作用和机制研究
- 批准号:82303803
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Lipid phosphatases as dynamic regulators of protein conformation
脂质磷酸酶作为蛋白质构象的动态调节剂
- 批准号:
9355654 - 财政年份:2016
- 资助金额:
$ 24.89万 - 项目类别:
Lipid phosphatases as dynamic regulators of protein conformation
脂质磷酸酶作为蛋白质构象的动态调节剂
- 批准号:
9164702 - 财政年份:2016
- 资助金额:
$ 24.89万 - 项目类别:
Transcriptional Control by the Global Regulator Spx
全局调节器 Spx 的转录控制
- 批准号:
7216693 - 财政年份:1992
- 资助金额:
$ 24.89万 - 项目类别:
Transcriptional Control by the Global Regulator Spx
全局调节器 Spx 的转录控制
- 批准号:
7392340 - 财政年份:1992
- 资助金额:
$ 24.89万 - 项目类别:
Molecular Characterization Of The Mitochondrial Dna Polymerase
线粒体 DNA 聚合酶的分子表征
- 批准号:
7734480 - 财政年份:
- 资助金额:
$ 24.89万 - 项目类别: